about
The Preclinical Research Progress of Stem Cells Therapy in Parkinson's DiseaseVirology- and immunology-based gene therapy for cancer.A possible anticancer agent, type III interferon, activates cell death pathways and produces antitumor effects.The Clinical Status of Stem Cell Therapy for Ischemic CardiomyopathyFas ligand DNA enhances a vaccination effect by coadministered DNA encoding a tumor antigen through augmenting production of antibody against the tumor antigen.Expression of a murine homolog of apoptosis-inducing human IL-24/MDA-7 in murine tumors fails to induce apoptosis or produce anti-tumor effects.The secreted form of p28 subunit of interleukin (IL)-27 inhibits biological functions of IL-27 and suppresses anti-allogeneic immune responses.Protective Effects of Chronic Intermittent Hypobaric Hypoxia Pretreatment against Aplastic Anemia through Improving the Adhesiveness and Stress of Mesenchymal Stem Cells in Rats.Interferon-lambda induces G1 phase arrest or apoptosis in oesophageal carcinoma cells and produces anti-tumour effects in combination with anti-cancer agents.Zoledronic acid produces antitumor effects on mesothelioma through apoptosis and S-phase arrest in p53-independent and Ras prenylation-independent manners.E1B-55 kDa-defective adenoviruses activate p53 in mesothelioma and enhance cytotoxicity of anticancer agents.Silencing of polo-like kinase (Plk) 1 via siRNA causes inhibition of growth and induction of apoptosis in human esophageal cancer cells
P50
Q26744445-28FB2842-A309-4AF1-B9F8-B241FDF2B5DCQ36476004-B9CBD5CF-3974-4DF9-A5A0-55E534A72569Q37947594-12CCE435-6961-4491-BD44-E5BEB94F183BQ38535126-EB0E7DB1-03FD-44B9-BF1C-24E49314AE4AQ38901316-706888AD-45D2-4B48-9E71-DEE3DB0321C2Q39369479-51E56B07-C22C-4DF7-8C74-E4D472239BFBQ39796152-5B3DFF53-EAF1-4D32-83AB-78AB53D4A984Q41169422-1C5CA451-0DC4-4961-8CE3-B583401EF5B7Q43251298-C2845BD0-933C-4D6E-8E35-F3D3AC6F4F17Q47937031-5B94459D-9A73-43DC-A0A2-EB0FBA0627D3Q53134006-35A989DC-84D9-447B-9C6F-49946CBD8C17Q81803693-56394BCF-2AD1-4F8D-89E1-C83CFE0CC240
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Quanhai Li
@ast
Quanhai Li
@en
Quanhai Li
@es
Quanhai Li
@nl
Quanhai Li
@sl
type
label
Quanhai Li
@ast
Quanhai Li
@en
Quanhai Li
@es
Quanhai Li
@nl
Quanhai Li
@sl
prefLabel
Quanhai Li
@ast
Quanhai Li
@en
Quanhai Li
@es
Quanhai Li
@nl
Quanhai Li
@sl
P106
P31
P496
0000-0003-3629-3856